Microsomal reductase activity in patients with thyroid neoplasms

Area of Science:

• Biochemistry
• Oncology
• Endocrinology

Background:

• Cytochrome b5-reductase (CYB5R) and cytochrome P450 reductase (CYPOR) are crucial for cell metabolism.
• Their roles in thyroid hormonogenesis and carcinogenesis remain largely unelucidated.
• Previous studies linked CYB5R activity to breast cancer metastasis, but not thyroid tumors.

Purpose of the Study:

• To investigate changes in CYB5R and CYPOR activity in benign and malignant thyroid conditions.
• To evaluate their potential as diagnostic and prognostic biomarkers for thyroid cancer.

Main Methods:

• Studied 36 patients with thyroid diseases: control euthyroid goiter (10), toxic goiter (14), and papillary thyroid cancer (PTC) (12).
• Assessed CYB5R and CYPOR activity using lucigenin-enhanced chemiluminescence stimulated by NADH and NADPH, respectively.

Main Results:

• CYB5R and CYPOR activity increased ~5- and 10-fold in toxic goiter, and ~15- and 30-fold in PTC, compared to controls.
• CYPOR activity showed a more pronounced increase than CYB5R.
• Follicular adenoma exhibited 2-4 fold lower reductase activity than euthyroid goiter and low-activity PTC.

Conclusions:

• Microsomal reductase activity varies significantly across thyroid pathologies.
• These enzymes represent promising biomarkers for differentiating benign from malignant thyroid tumors.